Assessment of Myocardial Viability With 99m Tc Sestamibi in Patients Undergoing Cardiac Transplantation
- 1 September 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 94 (5) , 1010-1017
- https://doi.org/10.1161/01.cir.94.5.1010
Abstract
Background99mTc sestamibi and 201Tl are tracers that allow equivalent detection of myocardial infarction. However, because sestamibi does not undergo as much time-dependent redistribution as does 201Tl, it has been considered suboptimal for the detection of myocardial viability. Methods and Results Fifteen consecutive patients with ischemic cardiomyopathy who underwent orthotopic cardiac transplantation received an intravenous injection of 99mTc sestamibi at 1 to 6 hours before transplantation. Rotational tomography of the excised, intact, native hearts was performed to quantify the extent of myocardial hypoperfusion. The hearts were then sliced and reimaged on a gamma camera, followed by pathological quantification of the extent and severity of scarred and normal myocardium. Samples of normally and abnormally perfused myocardium underwent gamma well counting to determine tissue radioactivity and were examined under light microscopy for delineation of myocardial structure after trichrome staining. The mean extent of scintigraphic scar quantified through the use of rotational tomography was 45±14% of the left ventricle and correlated closely with pathological scar size (r=.89), despite a slight overestimation. Scintigraphic scar size determined with planar imaging of the individual myocardial slices also correlated closely with pathological scar size (r=.88). A good correlation existed between tissue 99mTc sestamibi activity determined through well counting and histological evidence of myocardial viability (r=.89). Most hypokinetic and 40% of akinetic/dyskinetic myocardial segments contained scintigraphically and histologically normal myocardium. Conclusions99mTc sestamibi scintigraphy can be used to accurately quantify the extent of myocardial scarring. Furthermore, the relative sestamibi activity in perfusion defects, measured several hours after administration, is a good indicator of myocardial viability determined with microscopy.Keywords
This publication has 30 references indexed in Scilit:
- The hibernating myocardiumPublished by Elsevier ,2004
- Relation of left ventricular volume and function over one year after acute myocardial infarction to infarct size determined by technetium-99m sestamibiThe American Journal of Cardiology, 1991
- Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass graftingThe American Journal of Cardiology, 1990
- Comparison of thallium redistribution with rest “reinjection” imaging for the detection of viable myocardiumThe American Journal of Cardiology, 1990
- Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass graftingThe American Journal of Cardiology, 1989
- Incomplete redistribution in delayed thallium-201 single photon emission computed tomographic (SPECT) images: An overestimation of myocardial scarringJournal of the American College of Cardiology, 1988
- Regional dysfunction by equilibrium radionuclide angiocardiography: A clinicopathologic study evaluating the relation of degree of dysfunction to the presence and extent of myocardial infarctionJournal of the American College of Cardiology, 1987
- Reversibility of Cardiac Wall-Motion Abnormalities Predicted by Positron TomographyNew England Journal of Medicine, 1986
- Pathoanatomic correlates of regional left ventricular wall motion assessed by equilibrium radionuclide angiocardiography: A postmortem correlationThe American Journal of Cardiology, 1984
- A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.Circulation, 1981